Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Cognitive impairment among patients with multiple sclerosis: associations with employment and quality of life.
Finding NMO: The Evolving Diagnostic Criteria of Neuromyelitis Optica.
Alterations in brain white matter contributing to age-related slowing of task switching performance: The role of radial diffusivity and magnetization transfer ratio.
Considerations on long-term immuno-intervention in the treatment of multiple sclerosis: an expert opinion.
Effects of small-fiber neuropathy induced by resiniferatoxin on skin healing and axonal regrowth after burn.
Characterization of mouse spinal cord vascular network by means of synchrotron radiation X-ray phase contrast tomography.
NR1H3 p.Arg415Gln Is Not Associated to Multiple Sclerosis Risk.
Partial MHC class II constructs as novel immunomodulatory therapy for stroke.
Central pontine myelinolysis in a case of alcohol dependence syndrome.
Acute Disseminated Encephalomyelitis.
APE1/Ref-1 facilitates recovery of gray and white matter and neurological function after mild stroke injury.
Development and feasibility of the Help to Overcome Problems Effectively (HOPE) self-management intervention for people living with multiple sclerosis.
Laquinimod decreases Bax expression and reduces caspase-6 activation in neurons.
Influenza vaccination in patients with multiple sclerosis is possible with some considerations.
Acute Disseminated Encephalomyelitis After Influenza Vaccination: A Case Report.
Progressive multifocal leukoencephalopathy in a patient without apparent immunosuppression.
Programmed cell death and natural killer cells in multiple sclerosis: new potential therapeutic targets?
Identification of galectin-3 as a possible antibody target for secondary progressive multiple sclerosis.
Re: The effect of venous anatomy on the morphology of multiple sclerosis lesions: a susceptibility-weighted imaging study.
An attenuated immune response by Schwann cells and macrophages inhibits nerve regeneration in aged rats.
Vascular, glial, and lymphatic immune gateways of the central nervous system.
MD1003 (high-dose biotin) for the treatment of progressive multiple sclerosis: A randomised, double-blind, placebo-controlled study.
Vertebral hemangiomas in the thoracic spine of multiple sclerosis patients are connected with fewer demyelinating lesions at the same level. Possible impact on pathophysiology and clinical course.
Three cases of herpes zoster radiculitis in MS patients treated with natalizumab.
Pathophysiology, assessment and management of multiple sclerosis fatigue: an update.
Pages
« first
‹ previous
…
800
801
802
803
804
805
806
807
808
…
next ›
last »